Author(s):
Shaik Harun Rasheed, Kondapuram Parameshwar, K. Mallikarjuna Reddy, G. Sushmitha, Sesha Madhavi M.
Email(s):
parameshwarkp@gmail.com
DOI:
10.52711/2231-5691.2024.00037 
Address:
Shaik Harun Rasheed, Kondapuram Parameshwar*, K. Mallikarjuna Reddy,G. Sushmitha, Sesha Madhavi M.
Faculty of Pharmacy, Gurunanak Institutions Technical Campus - School of Pharmacy, Hyderabad - 501506, Telangana, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
In the ongoing fight against malaria, an age-old disease responsible for hundreds of thousands of deaths annually, advancements in nanotechnology present new horizons for innovative interventions. This review provides a comprehensive review of the current state of nanotechnology-driven solutions in malaria treatment and control, outlining the ground-breaking opportunities they present and their challenges. Nanoparticle-based drug delivery systems have shown enhanced therapeutic efficacy, targeted delivery, and reduced side effects. Similarly, nanotechnology has paved the way for improved diagnostic tools with higher sensitivity and rapid detection capabilities. Furthermore, nano-enhanced vector control strategies have emerged, aiming to tackle malaria transmission at its source. Despite these advancements, challenges such as scale-up, biosafety, environmental concerns, and cost considerations persist. By bridging the gap between current challenges and pharmaceutical strategies, this review sheds light on the future direction of nanotechnology in malaria eradication, underscoring the potential it holds for revolutionizing the field and bringing us closer to a malaria-free world.
Cite this article:
Shaik Harun Rasheed, Kondapuram Parameshwar, K. Mallikarjuna Reddy,G. Sushmitha, Sesha Madhavi M.. Nanotechnology-Driven Innovations in Malaria Treatment and Control: Current Challenges and Pharmaceutical Strategies. Asian Journal of Pharmaceutical Research. 2024; 14(3):235-1. doi: 10.52711/2231-5691.2024.00037
Cite(Electronic):
Shaik Harun Rasheed, Kondapuram Parameshwar, K. Mallikarjuna Reddy,G. Sushmitha, Sesha Madhavi M.. Nanotechnology-Driven Innovations in Malaria Treatment and Control: Current Challenges and Pharmaceutical Strategies. Asian Journal of Pharmaceutical Research. 2024; 14(3):235-1. doi: 10.52711/2231-5691.2024.00037 Available on: https://asianjpr.com/AbstractView.aspx?PID=2024-14-3-6
REFERENCES:
1. Krushna K. Zambare, Avinash B. Thalkari, Nagesh S. Tour. A Review on Pathophysiology of Malaria: A Overview of Etiology, Life Cycle of Malarial Parasite, Clinical Signs, Diagnosis and Complications. Asian J. Res. Pharm. Sci. 2019; 9(3): 226-230. doi: 10.5958/2231-5659.2019.00035.3
2. Anil K Agarwal, Abhishek Yadav, C. P., Paromita Kuity, Jaya Mishra. Development of Antimalarial Pharmacotherapy and its importance in Malaria Treatment/Public Health Program. Asian Journal of Pharmaceutical Analysis. 2022; 12(4): 233-2. doi.org/10.52711/2231-5675.2022.00038.
3. Wells TN, Alonso PL, Gutteridge WE. New medicines to improve control and contribute to the eradication of malaria. Nature reviews Drug discovery. 2009; 8(11): 879-91.
4. Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, Price RN. Identifying and combating the impacts of COVID-19 on malaria. BMC Medicine. 2020; 18(1): 1-7. doi.org/10.1186/s12916-020-01710-x
5. Russell TL, Beebe NW, Cooper RD, Lobo NF, Burkot TR. Successful malaria elimination strategies require interventions that target changing vector behaviours. Malar J. 2013; 12(1): 56. doi: 10.1186/1475-2875-12-56.
6. Krushna K. Zambare, Avinash B. Thalkari, Nagesh S. Tour. A Review on Pathophysiology of Malaria: A Overview of Etiology, Life Cycle of Malarial Parasite, Clinical Signs, Diagnosis and Complications. Asian J. Res. Pharm. Sci. 2019; 9(3): 226-230. doi: 10.5958/2231-5659.2019.00035.3
7. Kiran Patole, Anil Danane, Amit Nikam, Anuja Patil. Review on Nanotechnology and its utilization in Pharmaceuticals. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(4): 319-2. doi: 10.52711/2231-5659.2021.00050
8. Pagar Swati A., Suryawanshi Hemant K.. Nanotechnology- Finding proofs for its ancient origin. Asian J. Res. Pharm. Sci. 2021; 11(1): 65-70. doi: 10.5958/2231-5659.2021.00011.4
9. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy. 2003; 63(1): 17-36. doi: 10.1016/s0168-8510(02)00036-2. doi.org/10.1016/S0168-8510(02)00036-2
10. Smith T, Maire N, Ross A, Penny M, Chitnis N, Schapira A, Studer A, Genton B, Lengeler C, Tediosi F, De Savigny D. Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology. 2008; 135(13): 1507-16. doi:10.1017/S0031182008000371
11. Martens WJ, Niessen LW, Rotmans J, Jetten TH, McMichael AJ. Potential impact of global climate change on malaria risk. Environmental Health Perspectives. 1995; 103(5): 458-64. doi.org/10.1289/ehp.95103458
12. De Beaudrap P, Turyakira E, White LJ, Nabasumba C, Tumwebaze B, Muehlenbachs A, Guérin PJ, Boum Y, McGready R, Piola P. Impact of malaria during pregnancy-on-pregnancy outcomes in a Ugandan prospectivecohort with intensive malaria screening and prompt treatment. Malaria Journal. 2013; 12: 1-1. doi.org/10.1186/1475-2875-12-139
13. Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low‐and middle‐income countries. Annals of the New York Academy of Sciences. 2019; 1450(1): 15-31. /doi.org/10.1111/nyas.14092
14. Mishra M, Mishra VK, Kashaw V, Iyer AK, Kashaw SK. Comprehensive review on various strategies for antimalarial drug discovery. European Journal of Medicinal Chemistry. 2017; 125: 1300-20. doi.org/10.1016/j.ejmech.2016.11.025
15. Barnes KI, White NJ. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Tropica. 2005; 94(3): 230-40. doi.org/10.1016/j.actatropica.2005.04.014
16. Greenwood D. The quinine connection. Journal of Antimicrobial Chemotherapy. 1992 ; 30(4):417-27. doi.org/10.1093/jac/30.4.417
17. Warhurst DC. Antimalarial drugs: an update. Drugs. 1987; 33: 50-65. doi.org/10.2165/00003495-198733010-00003
18. Pérez B, Teixeira C, Albuquerque IS, Gut J, Rosenthal PJ, Prudêncio M, Gomes P. PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity. Med Chem Comm. 2012; 3(9): 1170-2. doi.org/10.1039/C2MD20113E
19. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clinical Infectious Diseases. 2002; 35(12): 1498-504. https://doi.org/ 10.1086/344901
20. Rishabh Aggarwal, Ashutosh Chamoli, Mayank Rawat, Anuj Nautiyal. A Review on Malaria, its Control and Management. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(2): 154-0. doi: 10.52711/2231-5659.2023.00027
21. Schellenberg D, Abdulla S, Roper C. Current issues for anti-malarial drugs to control P. falciparum malaria. Current Molecular Medicine. 2006; 6(2): 253-60. doi.org/10.2174/ 156652406776055168
22. Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iranian Journal of Medical Sciences. 2017; 42(2): 115.
23. Davis TM, Karunajeewa HA, Ilett KF. Artemisinin‐based combination therapies for uncomplicated malaria. Medical Journal of Australia. 2005; 182(4): 181-5.
24. Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug‐resistant Plasmodium falciparum malaria. The FEBS Journal. 2017; 284(16): 2569-78. doi.org/10.1186/s12936-018-2620-y
25. Ahmad SS, Rahi M, Ranjan V, Sharma A. Mefloquine as a prophylaxis for malaria needs to be revisited. International Journal for Parasitology: Drugs and Drug Resistance. 2021 1; 17: 23-6. doi.org/10.1016/j.ijpddr.2021.06.003
26. Castelli F, Odolini S, Autino B, Foca E, Russo R. Malaria prophylaxis: a comprehensive review. Pharmaceuticals. 2010; 3(10): 3212-39. doi.org/10.3390/ph3103212
27. McKeage K, Scott LJ. Atovaquone/Proguanil: A Review of its Use for the Prophylaxis of Plasmodium. Drugs. 2003; 63: 597-623. doi.org/10.2165/00003495-200363060-00006
28. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug safety. 2004; 27: 25-61. doi.org/10.2165/00002018-200427010-00003
29. Paik IH. Orally active and robust Artemisinin-derived trioxanes: Antimalarial, antiproliferative, and anticancer efficacies. The Johns Hopkins University; 2006.
30. Lin JT, Juliano JJ, Wongsrichanalai C. Drug-resistant malaria: the era of ACT. Current Infectious Disease Reports. 2010; 12: 165-73. doi.org/10.1007/s11908-010-0099-y
31. Betuela I, Robinson LJ, Hetzel MW, Laman M, Siba PM, Bassat Q, Mueller I. Primaquine treatment for Plasmodium vivax-an essential tool for malaria control and elimination in Papua New Guinea. Papua New Guinea Medical Journal. 2014; 57(1/4): 68-74. doi/10.3316/informit.828705526658515
32. Sangar Omkar S., Patil Aishwarya C., Payghan Santosh A.. Nanoparticles: As a Nano based Drug Delivery System. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(1): 11-6. doi.org/10.52711/2231-5659.2022.00003
33. Priyanka Khot, Kavita Nangare, Vaishali Payghan, Tejashree Kamble, Santosh Payghan. Drug Delivery Systems Based on Polymeric Micelles. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(1): 37-1. doi: 10.52711/2231-5659.2022.00007
34. Look M, Bandyopadhyay A, Blum JS, Fahmy TM. Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Advanced Drug Delivery Reviews. 2010; 62(4-5): 378-93. doi.org/10.1016/j.addr.2009.11.011
35. Swarnima Pandey, Vikas Srivastava. An Overview on Invasomes: Novel Vesicular Carrier for Transdermal Drug Delivery. Research Journal of Topical and Cosmetic Sciences. 2021; 12(2): 107-2. doi: 10.52711/2321-5844.2021.00015
36. Wang WE, Zhang MJ, Chu LY. Functional polymeric microparticles engineered from controllable microfluidic emulsions. Accounts of Chemical Research. 2014; 47(2): 373-84. doi.org/10.1021/ar4001263
37. Pagar Swati A., Suryawanshi Hemant K.. Nanotechnology- Finding proofs for its ancient origin. Asian J. Res. Pharm. Sci. 2021; 11(1): 65-70. doi: 10.5958/2231-5659.2021.00011.4
38. Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Advanced Drug Delivery Reviews. 2012; 64: 102-15. doi.org/10.1016/j.addr.2012.09.030
39. Abd Ellah NH, Abouelmagd SA. Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges. Expert Opinion on Drug Delivery. 2017; 14(2): 201-14. doi.org/10.1080/17425247.2016.1213238
40. Katta. Manogna, E. Nanda Krishna Reddy, T.N. Shilpa. Polymeric Novel Vesicular Drug Delivery System: An Updated Overview of Microspheres. Research J. Topical and Cosmetic Sci. 2017; 8(2): 64-72. doi: 10.5958/2321-5844.2017.00008.5
41. Rashidzadeh H, Tabatabaei Rezaei SJ, Adyani SM, Abazari M, Rahamooz Haghighi S, Abdollahi H, Ramazani A. Recent advances in targeting malaria with nanotechnology-based drug carriers. Pharmaceutical Development and Technology. 2021; 26(8): 807-23. doi.org/10.1080/10837450.2021.1948568
42. Alimardani V, Abolmaali SS, Tamaddon AM. Recent advances on nanotechnology-based strategies for prevention, diagnosis, and treatment of coronavirus infections. Journal of Nanomaterials. 2021; 1-20. doi.org/10.1155/2021/9495126
43. Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nature Nanotechnology. 2021; 16(4): 369-84. doi.org/10.1038/s41565-021-00866-8
44. Papaioannou I, Utzinger J, Vounatsou P. Malaria-anemia comorbidity prevalence as a measure of malaria-related deaths in sub-Saharan Africa. Scientific Reports. 2019; 9(1): 11323. doi.org/10.1038/s41598-019-47614-6
45. Ramazani A, Keramati M, Malvandi H, Danafar H, Kheiri Manjili H. Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL–PEG–PCL nanoparticles. Pharmaceutical Development and Technology. 2018; 23(9): 911-20. doi.org/10.1080/10837450.2017.1372781
46. Santos-Magalhães NS, Mosqueira VC. Nanotechnology applied to the treatment of malaria. Advanced Drug Delivery Reviews. 2010; 62(4-5): 560-75. doi.org/10.1016/j.addr.2009.11.024